y-Hydroxybutyrate (GHB) remains a popular drug of abuse, commonly known as liquid ecstasy; it is often? ingested with alcohol, with other drugs of abuse, or as its precursors y-butyrolactone and 1, 4-butanediol. GHB? intoxication results in CNS and respiratory depression and overdoses result in coma and death. A recent? review stated that GHB was the second most common drug detected in urine of young people presenting with? drug-induced coma, just behind cocaine. There is currently no specific treatment for GHB overdoses. The goal? of this proposal is to identify specific therapeutic interventions for the treatment of GHB overdoses, when GHB? is ingested alone or with ethanol. We have reported that GHB undergoes concentration-dependent? reabsorption in the kidney, due to transport by monocarboxylate transporters (MCTs), and that the? administration of MCT inhibitors can increase the renal and total clearances of GHB. Results from our? Preliminary Studies indicate that low doses of L-lactate combined with mannitol (an osmotic diuretic) increase? GHB renal and total clearances, decrease serum concentrations, and decrease the return to righting reflex? (RRR), a pharmacological end-point in rats, following high doses of GHB: the combined treatment resulted in? an additive/synergistic effect on RRR. Our hypothesis is that administration of MCT inhibitors alone, or? combined with mannitol, represents potential strategies for treating patients following overdoses of GHB. Our? specific aims are: (1) To determine the mechanism(s) underlying the effect of MCT inhibitors on GHB? toxicokinetics (TK) and toxicodynamics (TD). We will test the hypothesis that MCT inhibitors alter the TK and? TD of GHB by multiple mechanisms: increased renal clearance of GHB resulting in an increased total? clearance; inhibition of GHB brain uptake; and decreased formation of GABA in the brain. 2) To determine the? effects of mannitol on GHB TK and TD, and the mechanism(s) underlying the enhanced pharmacological effect? of L-lactate produced by concomitant mannitol administration. (3) To determine the mechanisms for the effect? of ethanol on the TK/TD of GHB, and the efficacy of MCT inhibitors and mannitol on GHB TK and TD following? the concomitant administration of ethanol. (4) To perform a clinical study in normal volunteers to evaluate the? efficacy of L-lactate/mannitol treatment in increasing the elimination and decreasing plasma concentrations of? GHB. Methods used in the proposal include in vivo studies in rats to determine plasma, brain tissue and? extracellular fluid (ECF) concentrations (by microdialysis) of GHB and the neurotransmitter y-aminobutyric acid? (GABA). The concentration-effect (RRR) relationship for GHB will be determined. Effects on brain uptake will? be determined using in situ brain perfusion, and in vitro studies of GHB brain metabolism will utilize? mitochondrial and cytosolic tissue preparations. The clinical study will provide """"""""proof-of-concept"""""""" that the? administration of L-lactate and mannitol can increase the elimination of GHB in humans, thereby representing? a potential treatment for GHB overdoses.
Showing the most recent 10 out of 35 publications
